Table 1. Activities of WT PfTR and Mutant Enzymes of the C-Terminal β–Turn−β Motif with Various Substratesa.
| mol of NADPH min–1 (mol of TR)−1 |
||||
|---|---|---|---|---|
| enzyme | PfTR | 90 μM Trx | 300 μM selenocystine | 5 mM lipoic acid |
| PfTR-GC1GGGKC2Gb | 1 | 500 ± 20 | 410 ± 30 | 90 ± 10 |
| PfTRΔ7c | 2 | NDd | 3 ± 0.2 | 140 ± 1 |
| PfTR-GC1GGGAC2Gb | 3 | 375 ± 20 | 350 ± 15 | 65 ± 5 |
| PfTR-GC1GGGKC2b | 4 | 7 ± 0.5 | 185 ± 10 | 70 ± 3 |
| PfTR-GC1GGGKC2GGb | 5 | 290 ± 10 | 400 ± 20 | 90 ± 2 |
In Tables 1–4, the main body of the enzyme is abbreviated as PfTR. The amino acid sequence of the C-terminal redox center is abbreviated with the one-letter amino acid codes representing the final seven C-terminal amino acids. Thus, the WT enzyme is abbreviated as PfTR-GC1GGGKC2G. Each of the mutants is denoted similarly with the mutant sequence of amino acids of the C-terminal redox center abbreviated with one-letter codes after the abbreviation PfTR.
Recombinant protein produced as a GST fusion.
Recombinant protein produced as an intein fusion.
No detectable activity.